Stephen Saad, Group Chief Executive, Aspen
The line between research based pharmaceutical companies and generic companies is today less and less relevant, as we have seen in the past few years generic companies climb up the…
KPMG in South Africa goes to market by line of business or industry, serving all of the key sectors across our economy. This focus allows our professionals to understand our clients’ needs rapidly, within the context of their specific business and the broader sector in which they operate. Our people consequently enjoy the growth opportunities that such an environment affords.
KPMG has 12 offices in South Africa, comprising our national office in Johannesburg and regional offices in Bloemfontein, Cape Town, Stellenbosch, Durban, East London, Nelspruit, Pietermaritzburg, Polokwane, Port Elizabeth, Pretoria and Secunda. With over 3,400 staff and more than 230 partners, we are one of the largest Audit, Tax and Advisory firms in the country.
KPMG in South Africa is owned by South Africans, headed up by a democratically elected Board. The Board elects the Chairman and the Chief Executive, who in turn appoints his/her Executive Committee.
We are proud to be South Africans, operating in the global marketplace. Our passion for the country, Transformation (Broad-Based Black Economic Empowerment) and the upliftment of our communities is self-evident.
We also played a pivotal role in bringing a number of our African national practices (including South Africa) together under a separate legal entity – KPMG Africa Limited to allow for seamless operational integration. Our Chief Executive, Trevor Hoole, is the Senior Partner of KPMG in South Africa.
KPMG in South Africa also plays an active role in KPMG’s global network. Roughly 40 professionals from the South African firm have active roles on international KPMG bodies – across the European, Middle Eastern and African (EMA) region and at a global level. With direct representation on KPMG’s International Board and International Council, as well as numerous international committees, working groups and networks, the South African firm is well positioned to think globally and act locally.
Contact
Johannesburg (Head Office)
KPMG Crescent, 85 Empire Road, Parktown, 2193
Private Bag 9, Parkview, 2122
Tel: +27 (0)11 647 7111
Fax: +27 (0)11 647 8000
The line between research based pharmaceutical companies and generic companies is today less and less relevant, as we have seen in the past few years generic companies climb up the…
Mr. Godard, you previously worked in Europe for Baxter Edwards Life Sciences, what made you decide to move to South Africa in a smaller company? It is a purely romantic…
Your professional career went back and forth between creating your own business and running a smaller and very dynamic structure and managing over a thousand of employees for multinational organizations.…
You were recently appointed at the head of Eli Lilly South African operations. What is the specific mission you have been given? Eli Lilly South Africa is in an interesting…
Since we interviewed you in 2005, there have been many changes in the market, from consolidation, an increasing generic penetration, to new healthcare reforms… How have you integrated these changes…
An emerging country with a dynamic market, South Africa is widely seen as the gateway to Africa. From major multinational pharmaceutical corporations to burgeoning local generic companies, a wide…
We interviewed Graham Somerville in 2004, the year when IHD, formerly jointly owned by 11 major pharmaceutical companies, was acquired by UTi. We are interviewing you today at the head…
Dr Pillay, South Africa recently became a member of BRICS. With this distinction, we need to improve our healthcare outcomes relative to other BRICS countries. All countries have challenges with…
The South African affiliate was established in June 2003. Could you come back on the main milestones in the company’s development from 2003 onwards? Yamanouchi as an entity was an…
Since we that came to South Africa in 2005 and interviewed you, what have been the main changes both in the market place, and within Sanofi as an organization? The…
In 2005, when Focus Reports interviewed you, you were more towards the start up phase of Pharma Dynamics; and you have significantly grown in the market since then. What new…
Mr. Ehsan, you are the General Manager of IMS Africa since January 2010. What is the strategic importance of South Africa for IMS Global and for your personal country portfolio?…
See our Cookie Privacy Policy Here
